Main Presentation Speaker: William B. Grant, Ph.D.
The main presentation topic this month will be on the roles of ultraviolet radiation exposure, vitamin D, and nutrition in maintaining optimal health.
Dr. Grant has studied the roles of nutrition, ultraviolet radiation exposure, and vitamin D in the risk of disease starting in 1996 when he was working as an atmospheric scientist at the NASA Langley Research Center in Virginia. He does research using the ecological study approach in which health outcomes for populations are averaged either for geographical units such as states or countries or by temporal variations which are compared statistically with risk-modifying factors such as UVB doses or dietary factors. He has made pioneering findings regarding the role of nutrition in the risk of Alzheimer’s disease and the roles of UV radiation exposure and vitamin D in the risk of many types of cancer, influenza/pneumonia, and autism. He has studied a wide range of diseases and health outcomes. His talk will present information on the role of UV exposure, vitamin D, and dietary factors in maintaining optimal health and reducing the risk of adverse health outcomes at all ages and conditions including pregnancy. He has over 300 publications listed at pubmed.gov (search Grant WB), of which a number are open access.
For more info, read the newsletter.
Secondary Presentation Speaker: Jerry Gin, PhD, MBA!
Jerry has spent 45 years in health care, with focus on pharmaceuticals, diagnostics, biotechnology. He is also Chairman of the Foundation for Mind-Being Research, a non-profit organization focused in the area of science and consciousness. In 2006, Jerry co-founded and is President/CEO of Nuvora, a company with a sustained delivery platform for products to be delivered to the oral cavity. Its first products are for dry mouth and oral health. In 2003, Jerry co-founded Chakshu, which is now Livionex, where he is Chairman. Livionex has a platform technology for metal modulation with applications in treating inflammation and removing biofilm. Its first product is a dental gel that is more effective in cleaning teeth as well as reducing gingivitis. In the pipeline are gels and lotions which have applications for wounds, burns, diabetic leg edema, arthritis and an eye drop for improving vision in persons with cataracts. In 1993, Jerry co-founded and was President/CEO of Oculex Pharmaceuticals and oversaw its successful start-up which eventually led to the acquisition by Allergan. The company developed the technology for controlled release delivery of drugs to the interior of the eye, specifically to treat macular edema. Prior to forming Oculex, Jerry co-founded his first company, ChemTrak, developers of the home cholesterol test commonly available in drug stores today. Jerry successfully took the company
public and ventured on to form Oculex.
Prior to ChemTrak, Jerry was the Director of New Business Development and Strategic Planning for Syva, the diagnostic arm of Syntex Pharmaceuticals, Director for Pharmaceutical and Diagnostic businesses for Dow Chemical, and Director of Dow’s clinical laboratories (now known as Quest Laboratories).
Jerry received his B.S. in Chemistry from the University of Arizona, his Ph.D. in Biochemistry from the University of California, Berkeley, post-doctoral research at the National Institutes of Health, and his M.B.A. from Loyola College.
For more info, read the newsletter.
NOTE: Meeting starts promptly at 7pm. Main speaker presentation begins at 7:20 p.m.
